Canopy Growth Corporation (CGC)

NASDAQ: CGC · Real-Time Price · USD

1.050

-0.030 (-2.78%)

At close: Aug 6, 2025, 4:00 PM

1.050

0.00 (0.00%)

After-hours: Aug 6, 2025, 7:14 PM EDT

Theseus Pharmaceuticals Stock Forecast

Stock Price Forecast

There is currently no analyst price target forecast available for Theseus Pharmaceuticals.

Price Target: $0.00 (0.00%)

Analyst Consensus: Hold

Target	Low	Average	Median	High
Price	n/a	n/a	n/a	n/a
Change	n/a	n/a	n/a	n/a

Analyst Ratings

According to 1 stock analyst, the rating for Theseus Pharmaceuticals is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.

Recommendation Trends

Rating	Feb '25	Mar '25	Apr '25	May '25	Jun '25	Jul '25
Strong Buy	0	0	0	0	0	0
Buy	0	0	0	0	0	0
Hold	0	1	1	1	1	1
Sell	2	1	1	1	1	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Pablo Zuanic Zuanic & Associates	Zuanic & Associates	Hold Initiates n/a	Hold	Initiates	n/a	n/a	Mar 27, 2025
Michael Lavery Piper Sandler	Piper Sandler	Sell Maintains $3 → $2	Sell	Maintains	$3 → $2	+90.48%	Jul 9, 2024
Lisa Lewandowski B of A Securities	B of A Securities	Sell Maintains $5.6 → $6.6	Sell	Maintains	$5.6 → $6.6	+528.57%	Sep 15, 2023
John Zamparo CIBC	CIBC	Sell Maintains $18 → $5	Sell	Maintains	$18 → $5	+376.19%	Jun 12, 2023
Michael Lavery Piper Sandler	Piper Sandler	Sell Maintains $20 → $10	Sell	Maintains	$20 → $10	+852.38%	May 2, 2023

More Analyst Ratings

Financial Forecast

Revenue This Year

275.58M

from 269.00M

2.45%

from 269.00M

Revenue Next Year

285.68M

from 275.58M

3.66%

from 275.58M

EPS This Year

-0.59

from -5.56

EPS Next Year

-0.46

from -0.59

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027	FY 2028
Period Ending	Mar 31, 2021	Mar 31, 2022	Mar 31, 2023	Mar 31, 2024	Mar 31, 2025	Mar 31, 2026	Mar 31, 2027	Mar 31, 2028
Revenue	546.65M	475.70M	333.25M	297.15M	269.00M	275.58M	285.68M	301.82M
Revenue Growth	37.08%	-12.98%	-29.95%	-10.84%	-9.47%	2.45%	3.66%	5.65%
EPS	-46.95	-7.92	-70.69	-8.79	-5.56	-0.59	-0.46	-0.68
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	9	5	3

Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027	2028
High	299.6M	303.5M	310.7M
Avg	275.6M	285.7M	301.8M
Low	256.4M	268.5M	290.0M

Revenue Growth

Revenue Growth	2026	2027	2028
High	11.4%	10.1%	8.8%
Avg	2.4%	3.7%	5.6%
Low	-4.7%	-2.6%	1.5%

EPS Forecast

EPS	2026	2027	2028
High	0.25	-0.30	-0.70
Avg	-0.59	-0.46	-0.68
Low	-1.04	-0.61	-0.65

EPS Growth

EPS Growth	2026	2027	2028
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.